Measles Outbreak Cases Cross 100 Mark In US, Australia Sees Sudden Surge Of The Infectious Disease

Updated Feb 23, 2025 | 11:46 AM IST

SummaryMeasles continues to create havoc with over 100 people infected in US. New health guidelines and advisories are being issued to ensure people remain safe and vigilant.
(Credit-Canva)

(Credit-Canva)

The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.

Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.

Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.

Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.

Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.

What Are The Symptoms Measles?

Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.

Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.

Why It Is Important To Get Vaccinated?

According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.

Who Should Get Vaccinated?

Kids Need Two Shots

All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.

College Students Need to Be Protected

Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.

Adults Need at Least One Shot

Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.

Travelers Need to Be Extra Careful

Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.

Healthcare Workers Must Be Immune

People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.

Women Thinking About Having Babies

Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.

End of Article

Two NIH Researchers Charged For Smuggling Deactivated Mpox Virus Into US

Updated Jun 3, 2026 | 07:00 PM IST

SummaryAccording to the US Department of Justice, the researchers were carrying a large black plastic case containing 113 vials when they arrived at Detroit Metropolitan Airport from the Republic of the Congo on January 25, this year.
Two NIH Researchers Charged For Smuggling Deactivated Mpox Virus Into US

Credit: iStock

Two researchers working at the National Institutes of Health (NIH) have been charged with allegedly bringing a deactivated mpox virus into the United States from the Republic of the Congo without a permit.

In a statement, the Department of Justice said Vincent Munster and Claude Kwe, from the NIH's Rocky Mountain Laboratory, were charged in a criminal complaint with conspiracy to smuggle monkeypox into the United States and making false statements to federal law enforcement agencies.

"These NIH experts apparently broke our laws by smuggling viral pathogens on a packed commercial airplane from an outbreak in the Republic of Congo. Let that sink in," said United States Attorney Jerome F. Gorgon Jr.

Who Are The Researchers?

According to the criminal complaint, Vincent Munster, 53, a citizen of the Netherlands, is the Chief of the Virus Ecology Section in the Laboratory of Virology at the Rocky Mountain Laboratory in Hamilton, Montana.

Claude Kwe, 38, a citizen of Cameroon, is a research fellow in Munster's section.

Both researchers worked on emerging viral pathogens and how those pathogens cross the species barrier. They work at a Biosafety Level 4 laboratory, which employs the highest level of biosafety precautions for scientific research involving known and potential human pathogens.

Also read: Western Australia Records 22 Mpox Infections In 2026; Seven Reported Last Week

What Did The Researchers Allegedly Carry?

According to the US Department of Justice, the researchers were carrying a large black plastic case containing 113 vials when they arrived at Detroit Metropolitan Airport from the Republic of the Congo on January 25, this year. Congo was experiencing a monkeypox outbreak at the time.

Customs and Border Protection (CBP) officers inspected and interviewed the researchers, who were carrying a large black plastic case.

"Munster and Kwe falsely told CBP officers that the black case contained diagnostics and testing equipment," the Department of Justice alleged. But when the FBI and CBP inspected the case and found 113 vials.

As per the investigators:

  • 17 of the first 20 tested vials contained deactivated mpox virus
  • 1 vial contained chickenpox virus
  • 2 vials contained human DNA

Investigation Ongoing

"No researchers should believe their positions, credentials, or professional status place them above the law," said Jennifer Runyan, Special Agent in Charge of the FBI Detroit Field Office.

"The allegations in this case are serious. They involve the dangerous and unlawful smuggling of deactivated Mpox virus into the United States and alleged efforts to mislead our federal agents," she added.

Read More: Bangladesh's Measles Crisis Deepens: Nearly 600 Children Dead Since March, Infections Set To Surge

Marcus L. Sykes, Special Agent in Charge at the Department of Health and Human Services Office of Inspector General (HHS OIG), said that "any deliberate effort to conceal and smuggle biological materials into the United States without proper authorization was a breach of public trust and could have placed the public at risk".

As per the officials, Munster and Kwe each face a maximum sentence of five years in prison if convicted. The investigation remains ongoing.

What Is Mpox?

Mpox is a viral disease caused by the monkeypox virus, which belongs to the same family of viruses as smallpox.

The virus spreads through close physical contact with an infected person, contaminated materials, or infected animals.

The illness generally lasts between two and four weeks and resolves on its own. However, severe disease can occur, particularly in children, pregnant women, and people with weakened immune systems.

Complications may include secondary infections, respiratory problems, and, in rare cases, death.

End of Article

844 Million Adults Worldwide Living With Chronic Kidney Disease: Lancet Study

Updated Jun 3, 2026 | 05:00 PM IST

SummaryThe three-part research series, led by global teams from India, the UK, China, Austria, and other countries, projects CKD to become the fifth leading cause of death globally by 2040.
844 Million Adults Worldwide Living With Chronic Kidney Disease: Lancet Study

Credit: Canva

Chronic kidney disease (CKD) — a progressive condition in which the kidneys become permanently damaged and lose their ability to filter blood effectively — affects an estimated 788 million to 844 million adults worldwide, according to new research published by The Lancet journal today.

The three-part research series, led by global teams from India, the UK, China, Austria, and other countries, projects CKD to become the fifth leading cause of death globally by 2040.

Experts identified limited access to testing, particularly in low- and middle-income countries, the absence of symptoms in the early stages of the disease, and the growing burden of non-communicable diseases as key factors driving the rise in CKD cases worldwide. They also called for sustained investment in diagnosis, treatment, and healthcare infrastructure to address the growing challenge.

CKD: Underdiagnosis and Lack of Symptoms

The researchers stressed that significant underdiagnosis of chronic kidney disease is a key factor endangering millions of patients worldwide.

Another concern is that mild and moderate stages of the disease often go undetected. Symptoms may develop only in the most severe stages, close to the time when dialysis or a kidney transplant may be required. Without successful treatment, the condition can be fatal.

The lack of symptoms likely contributes to low rates of diagnosis and awareness, said the experts in the research.

"Chronic kidney disease remains one of the most concerning conditions currently impacting global health. The overriding message from our series of research papers is that there remains a pressing need for attention and resources to be focused on this condition," said lead author Dr. Jennifer Lees, Senior Clinical Research Fellow at the University of Glasgow, UK.

Also read:16 Million Indians Die Due To Hypertension Every Year: AIIMS Doc

"There is huge potential to improve early diagnosis, treatment, and healthy lifespan by testing urine for protein routinely across a range of healthcare settings. This may be particularly important in those most at risk of underdiagnosis, including non-white populations and women," she added.

CKD And NCD Burden

The three research papers, presented at the ongoing European Renal Association Congress in Glasgow, Scotland, highlight that diabetes, hypertension, obesity, and cardiovascular disease are among the major drivers of CKD, with the risk of developing the disease increasing with age.

While CKD can affect anyone, it is more common in people who are Black or of South Asian origin. Compared with those without the condition, people with chronic kidney disease are more likely to be hospitalized, develop complications while in hospital, and be readmitted.

The studies also highlighted differences in diagnosis and treatment between men and women, alongside the need for integrated approaches to CKD prevention and treatment across a range of healthcare settings.

Read More: Emma Barnett: It Took 21 Years To Diagnose My Endometriosis

Call For Greater Investment In Kidney Care

The experts called for a renewed focus on CKD diagnosis and treatment.

"Chronic kidney disease affects 844 million people worldwide, yet access to even basic kidney testing remains deeply uneven," said Professor Luxia Zhang from Peking University, China.

"Advances in biomarkers, biopsy, and genetic testing now allow us to understand why an individual has kidney disease, not just that they have it. Realizing this benefit for patients everywhere will require sustained investment in diagnostics, laboratory capacity, and workforce," Zhang added.

End of Article

Ebola: Suspected Cases in DR Congo Drop To 116 After Hundreds Ruled Out Of Infection, Says WHO

Updated Jun 3, 2026 | 02:02 PM IST

SummaryThe WHO explained that the latest figures were significantly lower because hundreds of suspected cases had been discounted after further investigation.
Ebola: Suspected Cases in DR Congo Drop To 116 After Hundreds Ruled Out Of Infection, Says WHO

Credit: iStock

In a major relief amid the ongoing Ebola outbreak, the World Health Organization (WHO) said the number of suspected cases has dropped to 116 after hundreds were ruled out following investigation.

Earlier, the number of suspected cases had neared 1,000 in the Democratic Republic of Congo (DRC).

The global health agency said on Tuesday that there had been 48 deaths and six recoveries in Congo, Reuters reported.

In Uganda, there have been nine confirmed cases and one associated death, WHO spokesperson Christian Lindmeier told reporters in Geneva.

Later, Uganda's Ministry of Health confirmed six additional Ebola cases, bringing the country's total number of confirmed infections to 15.

The ministry said in a statement on X that all six newly confirmed cases were among contacts of previously confirmed patients.

Hundreds Of Suspected Cases Ruled Out

Lindmeier explained that the latest figures were significantly lower because hundreds of suspected cases had been discounted after further investigation.

"They have been cleared out and have either other diseases or have just had a fever and nothing else," he said.

Lindmeier added that the numbers would continue to fluctuate as more people are tested.

A suspected case includes anyone identified through surveillance systems or presenting with symptoms at a health facility. Confirmed cases include only those who test positive for the Bundibugyo strain of Ebola.

Last week, the WHO reported 906 suspected Bundibugyo Ebola cases in Congo, including 223 suspected deaths under investigation.

Subsequently, Jean Kaseya, Director-General of the Africa Centres for Disease Control and Prevention, told the Financial Times that more than 1,100 suspected cases were being investigated.

Testing has posed a major challenge during the outbreak because the commonly used Ebola diagnostic tests initially failed to detect the Bundibugyo strain, for which there is currently no approved vaccine.

Meanwhile, the US Centers for Disease Control and Prevention (CDC) website also listed 116 suspected cases and noted: "On May 29, the DRC Ministry of Health updated their total suspect case count to remove suspected cases that have been ruled out after investigation and suspected deaths that are pending the results of ongoing investigation."

Kenyans Protest Proposed US Ebola Treatment Facility

Also read: Western Australia Records 22 Mpox Infections In 2026; Seven Reported Last Week

The United States' plan to establish an Ebola treatment facility in Kenya has sparked public concern about cross-border infection risks and triggered protests.

The proposed 50-bed isolation centre would be staffed by US medical personnel and is intended to treat US citizens affected by the Ebola outbreak in the Democratic Republic of Congo.

Asked about the proposal during a White House briefing, Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, said keeping affected Americans closer to the outbreak zone would help speed up treatment.

"You have a golden hour in many of these instances around trauma, but for illnesses, it’s also relatively short, so we are confident, and the State Department’s working on this diligently, that they are going to be able to work out something with Kenya. There has already been a fair amount of communication around this issue," Oz said.

Although Kenya has not recorded any Ebola cases, the proposed quarantine facility has raised fears among residents who believe it could increase the risk of exposure to the virus.

End of Article